Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

2.80USD
4:41pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.80
Open
$2.80
Day's High
$2.80
Day's Low
$2.75
Volume
8,060
Avg. Vol
344,761
52-wk High
$8.61
52-wk Low
$1.41

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.37 December 19 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.80 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 1.48 1.57 1.40 0.00
Quarter Ending Dec-18 2 1.52 1.64 1.40 0.00
Year Ending Dec-18 2 5.22 5.30 5.14 0.74
Year Ending Dec-19 2 5.38 5.40 5.36 0.50
Earnings (per share)
Quarter Ending Sep-18 3 -0.37 -0.26 -0.51 --
Quarter Ending Dec-18 3 -0.38 -0.29 -0.52 -0.66
Year Ending Dec-18 3 -1.52 -1.23 -2.04 -2.56
Year Ending Dec-19 2 -1.17 -1.11 -1.24 -2.74

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.63 0.94 0.31 48.86
Quarter Ending Dec-17 1.49 1.62 0.13 8.93
Quarter Ending Sep-17 1.16 1.55 0.39 34.05
Quarter Ending Jun-17 0.75 1.15 0.39 52.12
Quarter Ending Mar-17 0.26 1.02 0.76 294.21

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.48 1.48 1.48 0.74 0.00
Quarter Ending Dec-18 1.52 1.52 1.52 0.76 0.00
Year Ending Dec-18 5.22 5.22 5.22 2.63 0.74
Year Ending Dec-19 5.38 5.38 5.38 2.71 0.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings